semaglutide
Ozempic Launches in India: Novo Nordisk's Diabetes and Weight Loss Drug Enters World's Second-Largest Diabetes Market
Dec 12, 2025 05:46 pm CST
Novo Nordisk has introduced Ozempic to the Indian market, pricing the diabetes medication at Rs 8,800-11,175 monthly across three dosages. The strategic launch targets India's significant diabetic population before generic competitors arrive in 2026. Beyond blood sugar control, Ozempic offers weight loss benefits and reduced cardiovascular risks, but remains prescription-restricted for medical use only.
Dangerous Side Effects: Chinese Woman Hospitalized After Unregulated Weight Loss Injections Cause Severe Health Complications
Dec 10, 2025 11:49 am CST
A 28-year-old Chinese woman experienced life-threatening complications, including vomiting blood and digestive tract damage, after using unregulated weight loss injections containing illegally sourced semaglutide. Despite losing 5kg in four days, she required emergency hospitalization, raising serious concerns about unsafe weight loss products and treatments circulating in the market.
Michelle Obama's Slimmer Appearance Sparks Unfounded Ozempic Speculation: What We Know About Her Health Journey
Nov 25, 2025 04:47 pm CST
Former First Lady Michelle Obama's recent photoshoot with Annie Leibovitz has triggered widespread social media speculation about possible Ozempic use after revealing a noticeably slimmer physique. Despite no evidence supporting these claims, online commentary has overshadowed her "Women" project. Obama previously attributed body changes to menopause in a 2022 interview, highlighting the broader trend of celebrity weight loss becoming subject to public scrutiny amid the popularity of weight loss medications.